Clinical Trials Logo

Filter by:
NCT ID: NCT03056235 Completed - Atrophic Acne Scar Clinical Trials

A Study to Evaluate the Efficacy of ELAPR002f in Females and Males With Atrophic Acne Scars

Start date: March 27, 2017
Phase: N/A
Study type: Interventional

The study is designed to evaluate the efficacy of two formulations of a cross-linked tropoelastin matrix given the product codes ELAPR002f (collectively referred to as ELAPR or ELAPR002) for the treatment of rolling atrophic acne scars when administered as intradermal implants.

NCT ID: NCT03056222 Completed - Clinical trials for Paroxysmal Atrial Fibrillation

CardioFocus vs. Contact Force Guided Pulmonary Vein Isolation in Paroxysmal Atrial Fibrillation

CF²
Start date: April 10, 2017
Phase: N/A
Study type: Interventional

The aim of the study is to compare the acute procedure and safety outcomes as well as long term clinical outcomes of 2 groups of patients treated with the HeartLight® Endoscopically Guided Laser Ablation (EGLA) or a commercially available Contact Force Sensing Irrigated Radiofrequency (RF) Ablation Catheter plus, at the operator's discretion, 3D Electroanatomical Mapping (EAM) for the treatment of Paroxysmal Atrial Fibrillation (PAF).

NCT ID: NCT03056040 Completed - Clinical trials for Paroxysmal Nocturnal Hemoglobinuria (PNH)

ALXN1210 Versus Eculizumab in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently Treated With Eculizumab

Start date: June 5, 2017
Phase: Phase 3
Study type: Interventional

The primary purpose of this study was to assess the noninferiority of ravulizumab compared to eculizumab in adult participants with PNH who were clinically stable after having been treated with eculizumab for at least 6 months.

NCT ID: NCT03055923 Completed - Asthma Clinical Trials

EXhaled Hydrogen Peroxide As a Marker of Lung diseasE (EXHALE) Pilot Study.

EXHALE Pilot
Start date: November 14, 2016
Phase:
Study type: Observational

This Pilot study evaluates the use of a new device called Inflammacheck and whether it can consistently measure hydrogen peroxide levels in exhaled breath condensate. It will also assess whether exhaled breath condensate hydrogen peroxide levels as measured by Inflammacheck can differentiate people with asthma and COPD from healthy individuals.

NCT ID: NCT03054311 Completed - Clinical trials for Mental Health Wellness 1

Lifestyle Matters: An Occupational Approach Towards Health and Well-being in Later Life

Start date: January 2004
Phase: N/A
Study type: Interventional

Lifestyle Matters is an occupational approach to healthy ageing, which helps older people to get the most out of life. The intervention is based on an American model of health promotion called Lifestyle Redesign. This was found to be highly effective in enhancing the physical and mental health, occupational functioning and life satisfaction of community living older adults in Los Angeles, USA. Weekly group meetings provide older people with the space, time and opportunity to share their experiences. Through a process of peer exchange and guidance, participants have the opportunity to reflect upon the range of activities that they engage with. They are then helped to begin to understand how these activities might impact on their health and well-being. However this approach alone cannot meet the complex needs of individual older people, and their specific and personal concerns. In recognition of this, the programme also includes monthly individual sessions with one of the group facilitators. The older person in partnership with the facilitator identifies a tailored programme to meet their individual needs, including the means by which they might work towards their personal goals. The individual programme is updated and refreshed in subsequent meetings over the months. During 2004/5 researchers at Sheffield Hallam University in partnership with other researchers in York and Leeds, and clinical colleagues in Sheffield explored the feasibility of delivering this intervention to older people living in the UK. The project was funded through the Sheffield Health and Social Research Consortium. The summary below is an account of the process and outcomes of delivering a Lifestyle Matters programme to two groups of community living older people during 2004/5.

NCT ID: NCT03053622 Completed - Healthy Clinical Trials

A Study of Mirikizumab (LY3074828) Injection in Healthy Participants

Start date: April 24, 2017
Phase: Phase 1
Study type: Interventional

This study is conducted to compare how much mirikizumab, in two different formulations, is absorbed into the bloodstream and how long the body takes to get rid of it, when given as an injection under the skin or into the veins. Side effects of the injection will be collected. Each participant will be in the study for about 18 weeks, including screening.

NCT ID: NCT03053440 Completed - Clinical trials for Waldenström's Macroglobulinemia

A Study Comparing BGB-3111 and Ibrutinib in Participants With Waldenström's Macroglobulinemia (WM)

ASPEN
Start date: January 25, 2017
Phase: Phase 3
Study type: Interventional

This study evaluated the safety, efficacy and clinical benefit of BGB-3111 (zanubrutinib) vs ibrutinib in participants with MYD88 Mutation Waldenström's Macroglobulinemia.

NCT ID: NCT03053102 Completed - Clinical trials for Paroxysmal Nocturnal Hemoglobinuria (PNH)

Study of Danicopan in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH)

Start date: March 31, 2017
Phase: Phase 2
Study type: Interventional

The purpose of this study was to determine the safety and efficacy of ACH-0144471 (also known as danicopan and ALXN2040) in currently untreated participants with PNH.

NCT ID: NCT03052881 Completed - Epiretinal Membrane Clinical Trials

Robotic Retinal Dissection Device Trial

R2D2
Start date: May 1, 2016
Phase: N/A
Study type: Interventional

The purpose of the study is to determine whether use of a robotic system improves the precision and therefore safety of high precision steps in retinal surgery. Two common surgical scenarios (ERM/ILM peel and sub retinal haemorrhage displacement surgery) that require a high degree of precision to avoid damage to the retina have been chosen for this trial. These steps also have been selected because they allow a clearly definable outcome measure e.g. time taken to complete a specific step in the operation. The main issue here is that the patients will be undergoing this procedure regardless of enrolment in the trial - the only difference being that for study participants the surgeon will perform parts of the operation with the assistance of the robot.

NCT ID: NCT03052465 Completed - Crohn Disease Clinical Trials

Magnetic Resonance Imaging of Motility in Crohn's 2

MIC2
Start date: November 16, 2015
Phase: N/A
Study type: Interventional

Crohn's disease (CD) is becoming more common. One of the main features of this disease is weight loss and malnutrition with symptoms such as tummy aches and bloating. These problems have a strong negative effect on the patients' quality of life but the causes of these problems are not well understood. Enteroendocrine cells are nutrient sensors in the bowel that secrete special chemicals (called hormones) that control appetite and the movements all the gut. The investigators think that this control mechanism goes wrong in Crohn's patients and they have set off to do more research on this. Looking at the inside work of the gut has always been difficult and at times unpleasant for patients, however recent developments in magnetic resonance imaging (MRI) are allowing the investigators to study the workings of the gut in greater detail and without discomfort for the patients. Our main objective is to investigate the difference in small bowel motility between CD patients with active ileal disease and healthy volunteers.